You are here: Home Faculty Pages Michael H. Nantz, Ph.D.

Michael H. Nantz, Ph.D.

by Wittliff,James L. last modified Sep 22, 2009 03:35 PM

Professor of Chemistry & Distinguished University Scholar

NantzEmail Michael Nantz
Phone Number: (502) 852 8069 (Office)
Fax Number: (502)-852-7214
Address: Department of Chemistry
University of Louisville
Louisville, KY 40292
Ph. D. 1987, Purdue University

Additional Appointments:

  • Professor, Chemistry Department, University of Louisville

 

Investigators:

  • Mr. Xuan Huang (4th year graduate student)
  • Mr. Souvik Biswas (3rd year graduate student)
  • Mr. Sebastien Laulhe (2nd year graduate student)
  • Ms. Stephanie Mattingly (1st year graduate student)
 

Research Interests:

  • Cationic Lipids and Polymers for Gene Delivery
  • Peptide-Based Prodrugs for Cancer Chemotheraputics
  • Applications of Nanoparticle-peptide conjugates

 

Selected Publications:

Textbooks:
  1. Modern Organic Synthesis: An Introduction GS Zweifel and MH Nantz.  WH Freeman & Co.: New York, 2006; ISBN: 0-7167-7266-3 (504 pages). 
  2. Solutions Manual for Modern Organic Synthesis MH Nantz, H Palandoken and GS Zweifel.  WH Freeman & Co.: New York, 2006; ISBN: 0-7167-7494-1 (218 pages). 

 

Journal Articles:
  1. Activation of CFTR by UCCF-029 and Genistein L Al-Nakkash, MF Springsteel, MJ Kurth and MH Nantz.  Bioorganic & Medicinal Chemistry Letters 2008, 18, 3874-3877.
  2. A Flexible Method for the Conjugation of Aminooxy Ligands to Pre-Formed Complexes of Nucleic Acids and Lipids. JG Hecker, GO Berger, KA Scarfo, S Zou and MH Nantz.  ChemMedChem 2008, 3, 1356-1361.
  3. A  Mild, Catalyst-Free Synthesis of 2-Aminopyridines B Poola, W Choung and MH Nantz.  Tetrahedron 2008, 64, 10798-10801.
  4. Whole Animal In Vivo Imaging After Transient Nonviral Gene Delivery to the Rat Central Nervous System ES Hauck, S Zou, K Scarfo, MH Nantz and JG Hecker.  Molecular Therapy 2008, 16, 1857-1864.

 

Patents & Licenses:

  • P1. MH Nantz, MJ Bennett and RW Malone
      • Cationic Transport Reagents
      • Filed: September 30, 1994; Issued: June 18, 1996
      • United States Patent No. 5,527,928
      • Patent licensed to Promega Corporation, Madison, WI.
  • P2. MH Nantz, MJ Bennett and RW Malone
      • Cationic Transport Reagents (Divisional)
      • Filed: May 16, 1996; Issued: April 28, 1998
      • United States Patent No. 5,744,625
      • Patent licensed to Promega Corporation, Madison, WI.
  • P3. MH Nantz, MJ Bennett, RP Balasubramaniam, AM Aberle and RW Malone
      • Polyfunctional Cationic Cytofectins, Formulations and Methods for Generating Active Cytofectin–Polynucleotide Transfection Complexes
      • Filed: September 17, 1996; Issued: October 20, 1998
      • United States Patent No. 5,824,812
      • Patent licensed to Promega Corporation, Madison, WI.
  • P4. MH Nantz, MJ Bennett and RP Balasubramaniam
      • Polyfunctional Cationic Cytofectins.
      • Filed: September 27, 1995; Issued: February 9, 1999
      • United States Patent No. 5,869,715
      • Patent licensed to Promega Corporation, Madison, WI.
  • P5. MH Nantz, MJ Bennett and RW Malone
      • Cationic Transport Reagents (CIP)
      • Filed: September 15, 1995; Issued: April 6, 1999
      • United States Patent No. 5,892,071
      • Patent licensed to Promega Corporation, Madison, WI.
  • P6. MH Nantz, MJ Bennett, RP Balasubramaniam, AM Aberle and RW Malone
      • Formulations and Methods for Generating Active Cytofectin–Polynucleotide Transfection Complexes.
      • Filed: July 15, 1996; Issued: July 20, 1999
      • United States Patent No. 5,925,623
      • Patent licensed to Promega Corporation, Madison, WI.
  • P7. MH Nantz and AM Aberle
      • Pentaerythritol Lipid Derivatives
      • Filed: April 3, 1998; Issued: March 28, 2000
      • United States Patent No. 6,043,390
      • 16
  • P8. MH Nantz and J Zhu
      • Ortho Ester Lipids
      • Filed: October 7, 1999; Issued: March 13, 2001
      • United States Patent No. 6,200,599
  • P9. MH Nantz and AM Aberle
      • Pentaerythritol Lipid Derivatives (Divisional)
      • Filed: March 27, 2000; Issued: November 13, 2001
      • United States Patent No. 6,316,421
  • P10. MJ Bennett, MH Nantz and SS Rothman
      • Method for Nucleic Acid Transfection of Cells
      • Filed: January 20, 2000; Issued: April 16, 2002
      • United States Patent No. 6,372,722
  • P11. MJ Bennett, SS Rothman and MH Nantz
      • Method for Nucleic Acid Transfection of Cells (Divisional)
      • Filed: January 18, 2001; Issued: September 23, 2003
      • United States Patent No. 6,624,149
  • PENDING EJ Niedzinski, MH Nantz, MJ Bennett and M Lizarzaburu
      • Polyamine-Mediated Transfection
      • Filed: May 31, 2002
      • United States Patent Application No. 60/385,234
  • PENDING J Wu and MH Nantz
      • Extracellular Superoxide Dismutase (EC-SOD) Gene Delivery To Prevent Oxidative Injury
      • Filed: WO 2005069938 (58 pp.); UC Case No. 2003-483-1
      • United States Patent Application No. pending
  • PENDING FA Gorin and MH Nantz
      • Novel Bioactive Amino Acid and Peptide Conjugates of Amiloride
      • Filed: WO 2005073247 (122 pp.); UC Case No. 2004-265-1
      • United States Patent Application No. pending
  • PENDING JG Hecker and MH Nantz
      • Novel Methods and Models for Rapid, Widespread Delivery of Genetic Material to the CNS Using Non-Viral Cationic Lipid-Mediated Vectors
      • Filed: December 14, 2006 (Ref P-3141PCT)
      • Priority from: US Provisional Application 60/751,470, Filed December 15, 2005
  • PENDING FA Gorin and MH Nantz
      • Inhibitors of Intracellular Urokinase Plasminogen Activator and Methods of Use Thereof
      • Filed: August 3, 2007 WO (xx pp.); UC Case No. 2007-265-1
      • Provisional United States Patent Application No. 60/953,796

 

Document Actions
Personal tools